Regenerative Medical Technology (RMTG) Enterprise Value (2017 - 2025)
Historic Enterprise Value for Regenerative Medical Technology (RMTG) over the last 9 years, with Q3 2025 value amounting to -$1.2 million.
- Regenerative Medical Technology's Enterprise Value fell 4175.71% to -$1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.2 million, marking a year-over-year decrease of 4175.71%. This contributed to the annual value of -$1.2 million for FY2024, which is 11974.21% down from last year.
- Latest data reveals that Regenerative Medical Technology reported Enterprise Value of -$1.2 million as of Q3 2025, which was down 4175.71% from -$1.6 million recorded in Q2 2025.
- In the past 5 years, Regenerative Medical Technology's Enterprise Value ranged from a high of -$530540.0 in Q4 2023 and a low of -$18.9 million during Q3 2021
- In the last 5 years, Regenerative Medical Technology's Enterprise Value had a median value of -$1.2 million in 2023 and averaged -$2.8 million.
- As far as peak fluctuations go, Regenerative Medical Technology's Enterprise Value plummeted by 9060242.03% in 2021, and later skyrocketed by 9065.11% in 2022.
- Over the past 5 years, Regenerative Medical Technology's Enterprise Value (Quarter) stood at -$3.0 million in 2021, then soared by 44.77% to -$1.6 million in 2022, then surged by 67.75% to -$530540.0 in 2023, then plummeted by 119.74% to -$1.2 million in 2024, then dropped by 1.7% to -$1.2 million in 2025.
- Its last three reported values are -$1.2 million in Q3 2025, -$1.6 million for Q2 2025, and -$1.2 million during Q1 2025.